Clinical and molecular characterization of an extended family with Fabry disease. Wattanasirichaigoon D*, Svasti J, Cairns JR, Tangnararatchakit K, Visudtibhan A, Keeratichamroen S, Ngiwsara L, Khowsathit P, Onkoksoong T, Lekskul A, Mongkolsiri D, Jariengprasert C, Thawil C, Ruencharoen S. J Med Assoc Thai. 2006 Sep;89(9):1528-35.

01 Sep 2006
0

Clinical and molecular characterization of an extended family with Fabry disease.

Wattanasirichaigoon D*, Svasti J, Cairns JR, Tangnararatchakit K, Visudtibhan A, Keeratichamroen S, Ngiwsara L, Khowsathit P, Onkoksoong T, Lekskul A, Mongkolsiri D, Jariengprasert C, Thawil C, Ruencharoen S.

J Med Assoc Thai. 2006 Sep;89(9):1528-35.

Tags

Share this

Related Posts

Discovery of novel naphthoquinone-chalcone hybrids as potent FGFR1 tyrosine kinase inhibitors: Synthesis, biological evaluation, and molecular modeling
Lertsuwan, J., Lertsuwan, K., Sawasdichai, A., Tasnawijitwong, N., Lee, K. Y., Kitchen, P., . . . Satayavivad, J. (2018). CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers (Basel), 10(9). doi:10.3390/cancers10090283

Recent Posts